Gregory Bailey's Net Worth

$505 Million

Estimate Recalculated Feb 7, 2024 04:00PM EST

Who is Gregory Bailey?

Gregory Bailey has an estimated net worth of $505 Million. This is based on reported shares across multiple companies, which include Biohaven Pharmaceutical Holding Co Ltd., AgeX Therapeutics, Inc., Opexa Therapeutics, Inc., MEDIVATION, INC., and Biohaven Ltd..

SEC CIK

Gregory Bailey's CIK is 0001329505

Past Insider Trading and Trends

2022 was Gregory Bailey's most active year for acquiring shares with 13 total transactions. Gregory Bailey's most active month to acquire stocks was the month of September. 2020 was Gregory Bailey's most active year for disposing of shares, totalling 31 transactions. Gregory Bailey's most active month to dispose stocks was the month of September. 2022 saw Gregory Bailey paying a total of $7,815,474.64 for 1,719,302 shares, this is the most they've acquired in one year. In 2022 Gregory Bailey cashed out on 2,679,985 shares for a total of $383,763,025.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Biohaven Pharmaceutical Holding Co Ltd. No price found

Investor

Gregory Bailey owns 2,583,658 units of Common Stock. Gregory Bailey used to own units in Common Shares but no longer holds any shares there. From 2017 to 2022 Gregory Bailey acquired a total of 1,839,999 shares in Biohaven Pharmaceutical Holding Co Ltd. at a cost of $11,841,538.80, Gregory also disposed a total of 3,338,801 shares of Biohaven Pharmaceutical Holding Co Ltd. equalling to $426,868,015.49.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.58M
$148.50
-$383,673,213.00
0
Oct 3
Form 4
+1.49%
38K
$148.04
$5,625,675.80
2.58M
Aug 19
Form 4
0
0
Apr 28
Form 4
0
0
May 5
Form 4
-1.36%
-34.97K
$79.31
-$2,773,218.33
2.55M
Scheduled
Oct 22 - Oct 23
Form 4
-0.32%
-8.30K
$78.93
-$655,293.46
2.58M
Scheduled
Oct 16 - Oct 19
Form 4
-0.26%
-6.73K
$78.87
-$530,740.45
2.59M
Scheduled
Oct 12
Form 4
-1.89%
-50.00K
$75.22
-$3,760,765.11
2.6M
Scheduled
Jul 8
Form 4
-3.84%
-105.64K
$73.98
-$7,815,521.50
2.65M
Scheduled
Jun 23 - Jun 24
Form 4
-8.16%
-244.36K
$71.88
-$17,565,931.60
2.75M
Scheduled
Jun 19 - Jun 22
Form 4
+15.77%
408.06K
$36.42
-$307.45
3M
Jun 5
Form 4
0
0
Apr 30
Form 4
+0.19%
5K
$37.65
$188,250.00
2.59M
Aug 20
Form 4
0
0
May 21
Form 4
+4.34%
107.5K
$9.29
$998,675.00
2.58M
Mar 25
Form 4
0
0
May 1
Form 4
-1.98%
-50.00K
$33.71
-$1,685,352.00
2.48M
Scheduled
Jan 31
Form 4
-0.63%
-16.00K
$32.79
-$524,640.00
2.53M
Scheduled
Jan 23
Form 4
-1.89%
-49.00K
$30.76
-$1,507,459.34
2.54M
Scheduled
Jan 19 - Jan 22
Form 4
-1.52%
-40.00K
$26.52
-$1,060,800.00
2.59M
Scheduled
Jan 16
Form 4
-4.10%
-50.00K
$28.71
-$1,435,527.84
1.17M
Scheduled
Jan 3 - Jan 4
Form 4
-3.13%
-39.43K
$26.31
-$1,037,290.10
1.22M
Scheduled
Dec 20
Form 4
-0.79%
-9.97K
$25.48
-$254,005.30
1.26M
Scheduled
Nov 29 - Nov 30
Form 4
-1.60%
-20.60K
$25.92
-$534,012.00
1.27M
Scheduled
Nov 24 - Nov 27
Form 4
+3,208.46%
1.25M
$17.00
1.29M
May 9
Form 3
0
0
No matching records found

AgeX Therapeutics, Inc. (AGE) Snapshot price: $0.3654

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 21
Form 4
0
0
Mar 11
Form 3
0
0
No matching records found

Opexa Therapeutics, Inc. (ACER) Snapshot price: $0.8675

Investor

Gregory Bailey owns 131,000 units of Common Stock which is worth $113,642.50. From 2006 to 2008 Gregory Bailey acquired a total of 31,000 shares in Opexa Therapeutics, Inc. at a cost of $33,790.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 26
Form 4
+31.00%
31K
$1.09
$33,790.00
131K
May 6
Form 4
0
0
Jun 18
Form 4
0
0
Jun 15
Form 4
0
0
Apr 25
Form 3
0
0
No matching records found

MEDIVATION, INC. No price found

Investor

Gregory Bailey owns 950,922 units of Common Stock. From 2005 to 2012 Gregory Bailey acquired a total of 461,279 shares in MEDIVATION, INC. at a cost of $1,839,755.36, Gregory also disposed a total of 464,851 shares of MEDIVATION, INC. equalling to $21,130,815.37.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+54.49%
243.77K
$5.68
$1,384,868.95
691.1K
Oct 30
Form 4
-3.62%
-16.80K
$53.60
-$900,480.00
447.33K
Scheduled
Oct 24
Form 4
-0.68%
-3.20K
$53.50
-$171,200.00
464.13K
Scheduled
Oct 16
Form 4
-7.88%
-40.00K
$58.10
-$2,323,800.00
467.33K
Scheduled
Oct 4 - Oct 5
Form 4
-5.58%
-30.00K
$56.39
-$1,691,716.92
507.33K
Scheduled
Oct 2
Form 4
-10.04%
-60.00K
$55.97
-$3,358,000.00
537.33K
Scheduled
Sep 25 - Sep 27
Form 4
-9.17%
-30.16K
$108.23
-$3,263,834.85
298.67K
Sep 6 - Sep 7
Form 4
0
0
Jul 16
Form 4
-5.33%
-18.50K
$91.49
-$1,692,565.00
328.82K
Jun 29 - Jul 3
Form 4
+0.87%
3K
$40.80
$122,399.00
347.32K
Nov 9
Form 4
0
0
Jul 15
Form 4
0
0
Jun 30
Form 4
-5.49%
-20.00K
$36.04
-$720,800.00
344.32K
Scheduled
Feb 23
Form 4
-5.20%
-20.00K
$36.82
-$736,400.00
364.32K
Scheduled
Feb 9
Form 4
-4.95%
-20.00K
$33.35
-$667,000.00
384.32K
Scheduled
Jan 27
Form 4
-2.41%
-10.00K
$38.00
-$380,000.00
404.32K
Scheduled
Jan 14
Form 4
-2.36%
-10.00K
$38.42
-$384,200.00
414.32K
Scheduled
Dec 23
Form 4
-2.30%
-10.00K
$36.40
-$364,000.00
424.32K
Scheduled
Dec 21
Form 4
-2.25%
-10.00K
$35.44
-$354,400.00
434.32K
Scheduled
Dec 17
Form 4
+138.06%
107K
$1.55
$165,850.00
184.5K
Dec 10
Form 4
-11.43%
-10.00K
$34.04
-$340,400.00
77.5K
Scheduled
Dec 4
Form 4
-3.71%
-10.00K
$31.49
-$314,900.00
259.82K
Scheduled
Dec 1
Form 4/A
-4.93%
-14.00K
$29.00
-$406,000.00
269.82K
Scheduled
Nov 20
Form 4
-4.93%
-14.00K
$25.99
-$363,860.00
269.82K
Scheduled
Nov 20
Form 4
-3.40%
-10.00K
$25.99
-$259,900.00
283.82K
Scheduled
Sep 14
Form 4
+51.84%
100.31K
$12.36
$1.20
293.82K
Jul 9
Form 4
0
0
Jun 30
Form 4
-9.37%
-20.00K
$21.01
-$420,194.00
193.51K
Scheduled
Jun 10
Form 4
-6.56%
-15.00K
$24.02
-$360,354.00
213.51K
Scheduled
May 22 - May 26
Form 4
-8.78%
-22.00K
$19.04
-$418,770.00
228.51K
Scheduled
Jan 22
Form 4
-8.07%
-22.00K
$29.70
-$653,404.40
250.51K
Scheduled
Sep 17
Form 4
-7.47%
-22.00K
$19.00
-$418,000.00
272.51K
Scheduled
Jul 18 - Jul 21
Form 3/A
0
0
Form 4
0
0
Jun 16
Form 4
0
0
Jun 15
Form 4
0
0
Aug 5
Form 3
0
0
No matching records found

Biohaven Ltd. (BHVN) Snapshot price: $47.81

Investor

Gregory Bailey owns 1,525,788 units of Common Shares which is worth $72,947,924.28. In the year 2022 Gregory Bailey acquired a total of 1,537,763 shares in Biohaven Ltd. at a cost of $2,591,892.90, Gregory also disposed a total of 11,975 shares of Biohaven Ltd. equalling to $89,812.50.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.18%
17.82K
$22.57
$402,094.06
1.53M
Oct 4
Form 4
0
0
May 2
Form 4
+15.29%
200K
$10.50
$2,100,000.00
1.51M
Oct 25
Form 4
1.31M
$5.35
-$13.66
1.31M
Oct 3
Form 3
0
0
No matching records found